Search results
Results from the WOW.Com Content Network
J&J’s Red River Talc unit made its filing in the U.S. Bankruptcy Court for the Southern District of Texas. ... any settlement J&J reached with some claimants would still leave holdouts or future ...
J&J's proposed settlement would pay talc claimants about $10 billion over 25 years. The present value of the settlement is roughly $8 billion after J&J recently agreed to kick in an additional $1. ...
That would cap its liability for all existing and future talc claims at the $8 billion it agreed to place in a settlement trust. J&J agreed to fund the proposed settlement trust over 25 years.
J&J has announced plans to finalize a $6.48 billion global settlement through the bankruptcy of a subsidiary company, after earlier efforts were rebuffed twice by federal courts. J&J says the ...
Johnson & Johnson (J&J) is an American multinational pharmaceutical, biotechnology, ... In 2012 Johnson and Johnson proposed a settlement with the shareholders ...
(Scan J&J’s latest SEC filing for a précis of these latest brushes with the law). Beyond that, there’s the larger question of whether the honor system works to ensure that companies with Johnson & Johnson’s Risperdal record, run by the same people who created that record, tell the FDA everything, good and bad, about all of their clinical ...
Tuesday's verdict comes as J&J seeks to resolve claims by more than 62,000 people who say that they got ovarian and other gynecological cancers from talc through a nearly $9 billion settlement in ...
The settlement amount includes both the civil (False Claims Act) settlement and criminal fine. Glaxo's $3 billion settlement included the largest civil False Claims Act settlement on record, [1] and Pfizer’s $2.3 billion ($3.5 billion in 2022) settlement including a record-breaking $1.3 billion criminal fine. [2]